longbridge

BeOne Medicines

688235
----

All Shareholders

Shareholder Type

  • Institutions53.54%
  • Public and others17.65%
  • Public companies16.66%
  • Hedge funds7.77%
  • Others4.37%

Major Shareholders

Major Shareholders Latest
Shareholder
Amgen Inc.
16.66%18.94M0.39%+0
Capital Research and Management Company
8.43%9.58M2.18%+2.52M
Baker Bros. Advisors LP
7.77%8.84M0.09%-46.75K
PRIMECAP Management Company
4.41%5.01M0.07%+32.75K
Hillhouse Investment Management, Ltd.
3.73%4.24M1.02%-1.03M
John OylerCo-Founder, Executive Chairman & CEO
3.12%3.54M0.31%-328.70K
BlackRock, Inc.
2.83%3.21M<0.01%+11.60K
China Asset Management Co. Ltd.
2.64%3.00M<0.01%+23.92K
Vanguard Capital Management, LLC
2.38%2.71M0.02%+38.02K
FMR LLC
2.16%2.45M1.14%-1.22M
Citadel Advisors LLC
1.25%1.43M0.32%+393.22K
China Universal Asset Management Company Ltd.
1.22%1.39M0.03%-415.00
Norges Bank Investment Management
1.11%1.27M0.04%+75.53K
Hang Seng Investment Management Limited
0.79%902.47K0.11%-121.18K
T. Rowe Price Group, Inc.
0.78%888.38K0.05%-49.95K
ICBC Credit Suisse Fund Management Co., Ltd
0.75%857.08K0.02%+0
Temasek Holdings (Private) Limited
0.74%845.73K0.03%-16.91K
GF Fund Management Co., Ltd.
0.72%822.78K<0.01%-45.00
Baillie Gifford & Co.
0.66%745.13K0.10%+9.61K
Xiaodong WangCo-Chairman of Scientific Advisory Board, Non-Executive Director & Co-Founder
0.63%716.43K<0.01%-5.65K
© 2026 Longbridge｜Terms of ServicePrivacy Policy